Imfinzi side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Imfinzi. Common side effects include death among females and death among males.
The phase IV clinical study is created by eHealthMe based on 4,563 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,563 people who take Imfinzi and have side effects are studied.
What is Imfinzi?
Imfinzi has active ingredients of durvalumab. eHealthMe is studying from 4,563 Imfinzi users for its effectiveness, alternative drugs and more.
Number of Imfinzi reports submitted per year:
Imfinzi side effects by time on the drug *:
Imfinzi side effects by gender *:
Imfinzi side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Imfinzi?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on durvalumab (the active ingredients of Imfinzi) and Imfinzi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Imfinzi:
- Imfinzi (4,563 reports)
Common Imfinzi side effects:
- Death: 708 reports
- Breathing difficulty: 182 reports
- Fatigue (feeling of tiredness): 150 reports
- Rashes (redness): 131 reports
- Fever: 128 reports
- Diarrhea: 109 reports
All Imfinzi side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Paclitaxel and Joint Pain - 4 seconds ago
- Losartan and Eyelid Oedema - 5 seconds ago
- Micro-K and Chest Pain - 8 seconds ago
- Micardis and Taste - Impaired - 9 seconds ago
- Hydrochlorothiazide and Ovarian Cysts - 10 seconds ago
- Micro-K and Suicide Attempt - 12 seconds ago
- Miconazole Nitrate and Pain - 13 seconds ago
- Metronidazole and Back Pain - 14 seconds ago
- Micardis and Gastric Ulcer - 15 seconds ago
- Miacalcin and Chest Pain - 18 seconds ago